|
2010-12-28 |
InCarbacel-II |
CIGB |
Registered |
|
2008-10-16 |
FASECU I |
CIGB |
Registered |
|
2008-09-18 |
Tisuacryl® in Dental Hyperesthesia |
BIOMAT |
Registered |
|
2010-12-27 |
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
CIGB |
Registered |
|
2010-12-24 |
CIGB-128 administration to patients with surgically-treated keloids. |
CIGB |
Registered |
|
2010-12-24 |
Application of CIGB-128 in keloid patients undergoing surgical exeresis. |
CIGB |
Registered |
|
2009-02-26 |
CITOPROT-III |
CIGB |
Registered |
|
2008-07-29 |
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine. |
FINLAY |
Registered |
|
2008-07-29 |
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET. |
FINLAY |
Registered |
|
2010-12-17 |
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I. |
CIM |
Registered |
|
2008-07-29 |
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age. |
FINLAY |
Registered |
|
2008-07-29 |
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers. |
FINLAY |
Registered |
|
2010-12-27 |
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. |
CIM |
Registered |
|
2008-09-19 |
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba. |
FINLAY |
Registered |
|
2010-12-24 |
InCCNM -I |
CIGB |
Registered |
|
2008-09-12 |
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique. |
FINLAY |
Registered |
|
2009-12-24 |
InCroMiel I |
CIGB |
Registered |
|
2008-07-29 |
Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants. |
FINLAY |
Registered |
|
2010-12-24 |
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2). |
CIGB |
Registered |
|
2010-12-24 |
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers. |
CIGB |
Registered |
